| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 01/13/2005 | WO2003074073A3 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |
| 01/13/2005 | US20050010052 P2X7 receptor (a ligand-gated ion channel) antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases; osteoarthritis |
| 01/13/2005 | US20050010047 Angiogenesis inhibitors; psoriasis; rheumatic disorders; chronic obstructive pulmonary disease |
| 01/13/2005 | US20050010042 Expression vector comprising nucleotide sequences comprising pro-polypeptide for use in the diagnosis, prevention and treatment of cell proliferative, inflammatory, cardiovascuar and nervous system disorders |
| 01/13/2005 | US20050009917 Prostaglandin, e.g., 1R,2R,3R,5R)-5-halo-2-[(1E,3S)-3-cycloalkyl-3-hydroxy-1-propenyl]-3-hydroxycyclopentyl]-(5Z)-5-alkenoic acids; treating in particular, symptoms of atopic dermatitis |
| 01/13/2005 | US20050009902 Treating any types of pruritus such as ocular pruritus, skin pruritus and systemic pruritus with a cannabinoid agonist such as palmidrol and anandamide or a derivative |
| 01/13/2005 | US20050009894 Benzimidazole derivatives and their use as KDR kinase protein inhibitors |
| 01/13/2005 | US20050009872 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors |
| 01/13/2005 | US20050009867 Quinoline derivatives and their use as tyrosine kinase inhibitors |
| 01/13/2005 | US20050009838 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 01/13/2005 | US20050009812 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists |
| 01/13/2005 | US20050009808 Azabicyclo compound matrix metalloprotease inibitor and skin preparation |
| 01/13/2005 | US20050009778 Method for treating retinal degeneration with purinergic receptor agonists |
| 01/13/2005 | US20050009755 (74)(3S)-3-amino-1-(1-benzyl-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-4-yl)-5-methyl-2-heptanone for example; cysteine protease inhibitors; treating bone resorption diseases such as osteoporosis |
| 01/13/2005 | US20050009752 Novel peptides and medicinal uses thereof |
| 01/13/2005 | US20050009144 Transgenic cell comprising nucleotide sequences coding endostatins for use as tool in identifying modulators for treatment and prevention of cell proliferative and angiogenesis-related disorders |
| 01/13/2005 | CA2530081A1 Ophthalmic compositions for treating ocular hypertension |
| 01/12/2005 | EP1495757A1 Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative |
| 01/12/2005 | EP1495756A1 Severe sepsis preventive therapeutic agent |
| 01/12/2005 | EP1495120A2 Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification |
| 01/12/2005 | EP1495113A2 Stimulation of nerve cell regeneration |
| 01/12/2005 | EP1495053A2 Angiopoietin-2 specific binding agents |
| 01/12/2005 | EP1495023A1 Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same |
| 01/12/2005 | EP1495022A1 Diazabicyclo alkane derivatives with nk1 antagonistic activity |
| 01/12/2005 | EP1495020A1 N-(morpholin-2yl) methyl acetamide derivatives as ccr-3 antagonists useful in the treatment of inflammatory diseases |
| 01/12/2005 | EP1495017A2 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| 01/12/2005 | EP1495005A1 Pyrazole compounds as anti-inflammatory and analgesic agents |
| 01/12/2005 | EP1494992A2 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 01/12/2005 | EP1494681A2 Methods of simultaneously treating ocular rosacea and acne rosacea |
| 01/12/2005 | EP1494672A1 Aminocarbonyl substituted pyridines, pyridazines, pyrimidines, pyrazines and triazines having antiangiogenic activity |
| 01/12/2005 | EP1494667A1 Imidazole compounds as anti-inflammatory and analgesic agents |
| 01/12/2005 | EP1307216A4 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use |
| 01/12/2005 | EP1299383B1 Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders |
| 01/12/2005 | EP1299373B1 Cyclic substituted aminomethyl compounds and medicaments containing said compounds |
| 01/12/2005 | EP1185241B1 Compositions containing avenanthramides from oat extract |
| 01/12/2005 | EP1171423B1 Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands |
| 01/12/2005 | EP1105370B9 Novel aryl sulphonamides and analogues |
| 01/12/2005 | EP1030851B1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 01/12/2005 | EP0944604B1 Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 01/12/2005 | CN1564816A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 01/12/2005 | CN1564685A Pyrrolidinone derivatives |
| 01/12/2005 | CN1564683A Methods for treating dry eye by a combination of an antiinflammatory steroid and a MUC-1 secretagogue |
| 01/12/2005 | CN1564682A Compositions for potentiating glutatthione |
| 01/12/2005 | CN1563087A Polypeptide of ramification of ciliary nerves nutrilite for curing obesity |
| 01/12/2005 | CN1562352A Technique for producing injection of freeze drying powder of A type botulinus toxin in use for treatment, and formula of protectant of freeze drying powder |
| 01/12/2005 | CN1562121A Medicine for treating canker and preparing method |
| 01/12/2005 | CN1562076A Chinese-western compound preparation for treating ear diseases |
| 01/12/2005 | CN1562047A Glycerin invert sugar injection |
| 01/12/2005 | CN1562038A L-ofloxacin lactate slow release gels for eye and its preparing method |
| 01/12/2005 | CN1562033A Gatifloxacin gels foreye and its preparing method |
| 01/12/2005 | CN1562032A Gatifloxacin gels ear drops and its preparing method |
| 01/12/2005 | CN1562030A Gatiflxacin eye gels based on HPMC medium and its preparing method |
| 01/12/2005 | CN1562025A Cinrofloxacin eye preparation formula and its using method |
| 01/12/2005 | CN1562002A Novel anti-biological cell free redical oxidation injury mixture |
| 01/11/2005 | US6841684 Imidiazoles having reduced side effects |
| 01/11/2005 | US6841567 Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 01/11/2005 | US6841564 Tri-aryl-substituted-ethane PDE4 inhibitors |
| 01/11/2005 | CA2269128C Piperazino derivatives as neurokinin antagonists |
| 01/11/2005 | CA2215351C Process for isolating galanthamine |
| 01/11/2005 | CA2151443C Cycloheptimidazole derivatives, method of manufacturing the same and therapeutic agents containing these compounds |
| 01/11/2005 | CA2104909C Decahydroisoquinolines as excitatory amino acid receptor antagonists |
| 01/06/2005 | WO2005001469A1 Method of acidic polysaccharide analysis and kit for the analysis |
| 01/06/2005 | WO2005000829A1 Cannabinoid receptor modulator |
| 01/06/2005 | WO2005000825A1 Thiazolimine compound and oxazolimine compound |
| 01/06/2005 | WO2005000406A2 Treatment of amyloid- and epileptogenesis-associated diseases |
| 01/06/2005 | WO2005000317A1 Enhancement of activity and/or duration of action of soft anti-inflammatory steroids for topical or other local application |
| 01/06/2005 | WO2005000306A1 Flupirtine preparation for treating neurodegenerative disorders of the visual system and diabetes mellitus |
| 01/06/2005 | WO2003042177A8 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 01/06/2005 | US20050004360 Compounds and methods for modulation of estrogen receptors |
| 01/06/2005 | US20050004180 Conditions mediated by beta chemokine receptor 2, monocyte chemotactic protein 1 and/or their interaction; such as 4-acetyl-5-cyclohexyl-3-amino-1-(4-methylphenyl)-1,5-dihydro-2H-pyrrol-2-one |
| 01/06/2005 | US20050004167 Such as dibenzofuran-2-carboxylic acid 2-(phenylsulfonyl)hydrazide |
| 01/06/2005 | US20050004153 inhibitors of Lymphocyte Function-associated Antigen 1 (LFA-1)/intercellular adhesion molecule (ICAM); use treating transplant rejection, rheumatoid arthritis, diabetes, inflammatory bowel disease, and chronic obstructive pulmonary disease; 2,4-dioxo-1,3,7-triazaspiro[4.4]nonanes |
| 01/06/2005 | US20050004140 Such as n-(4-fluorobenzyl)-6-(4-methyl-1H-imidazol-1-yl)pyrazin-2-amine; protein kinase associated disease states |
| 01/06/2005 | US20050004135 Pyrazole ether derivatives as anti-inflammatory/analgesic agents |
| 01/06/2005 | US20050004133 Inhibiting ligand gated ion channel vanilloid receptor (VR1); pain relievers; such as 6-(3,4-dichloro-phenyl)-N-(2-oxo-2,3-dihydro-1H-benzoimidazol-5-yl)-nicotinamide |
| 01/06/2005 | US20050004132 Pain, immune diseases, inflammatory disorders; low toxicity; such as 1-[2-(3-(4-Pyridyl)phenyl)ethyl]-4-(3-(trifluoromethyl)phenyl)-1,2,3,6-tetrahydropyridine 1-oxide |
| 01/06/2005 | US20050004116 Triazole inhibitors of type 2 methionine aminopeptidase |
| 01/06/2005 | US20050004115 such as 4-(4-(2-Fluorobenzyloxy)phenyl)-4-oxobutyric acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 01/06/2005 | US20050004096 Indole derivatives, process for producing the same and drugs containing the same as the active ingredient |
| 01/06/2005 | US20050004047 Bactericides; antiprotozoa agents |
| 01/06/2005 | US20050003353 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 01/06/2005 | US20050003352 Comprises recombinant mitochondrial transport protein for diagnosis, prevention and treatment of alzheimer's, diabetes, parkinson's, huntington's, cancers |
| 01/06/2005 | US20050003029 Treating retinal and choroidal edemas and/or hemorrhages; preserving eyesight |
| 01/06/2005 | US20050003014 Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs |
| 01/06/2005 | US20050002970 Enhancing flowability and lubricity; artificial tears, ocular lubricants |
| 01/06/2005 | US20050002954 Peptide-based vaccine for influenza |
| 01/06/2005 | US20050002950 Vaccine preventing infection |
| 01/06/2005 | US20050002936 Methods and compositions useful for inhibition of angiogenesis |
| 01/06/2005 | US20050002930 Methods of production and use of anti-integrin antibodies for the control of tissue granulation |
| 01/06/2005 | CA2556706A1 Treatment of amyloid- and epileptogenesis-associated diseases |
| 01/06/2005 | CA2531020A1 Cannabinoid receptor modulator |
| 01/05/2005 | EP1493743A1 Substituted bipiperidine intermediates and derivatives thereof |
| 01/05/2005 | EP1492797A1 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the production thereof |
| 01/05/2005 | EP1492793A1 New-4-(pyrrolopyrimidin-6-yl)benzenesulphonamide derivatives |
| 01/05/2005 | EP1492789A1 Tropane derivatives as ccr5 modulators |
| 01/05/2005 | EP1492779A1 Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity |
| 01/05/2005 | EP1492777A1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidase inhibitors |
| 01/05/2005 | EP1492774A2 Pyrimidone derivatives useful for the treatment of inflammation and immunological diseases |
| 01/05/2005 | EP1492771A1 Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents |
| 01/05/2005 | EP1492761A2 Amino acids with affinity for the alpha-2-delta-protein |